1. Sci-Finder, Predicted properties. https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf, (accessed 10 Mar 2021).
2. Global hepatitis report, Geneva, Switzerland: World Health Organization. https://www.who.int/hepatitis/publications/globalhepatitisreport2017/en/, 2017 (accessed 8 May 2021).
3. Recurrent fixed drug eruption caused by citiolone;Barrio;J. Invest. Allergol. Clin. Immunol.,1997
4. Study of cytologic and enzymatic modifications during hepatocyte aggressions (original action of citiolone, a cyto-membrane protector: value of its use in the treatment of hepatic diseases);Moretti;Cah. Med.,1970
5. Use of citiolone in chronic hepatitides. Results of a research with clinical and laboratory controls;Miglio;Minerva Med.,1977